Guenther-Gerhard Jung

Title: Guenther-Gerhard Jung: Innovator in T Cell Research

Introduction

Guenther-Gerhard Jung is a notable inventor based in Tübingen, Germany. He has made significant contributions to the field of immunology, particularly in the development of diagnostic and therapeutic applications involving T lymphocytes. With a total of 2 patents, his work has had a profound impact on the understanding and treatment of viral infections.

Latest Patents

Jung's latest patents include groundbreaking inventions such as "Antigen-specific, activated T lymphocytes, detection and use." This invention focuses on autoreactive peptides, peptide-MHC complexes, and T cell subpopulations that react to these compounds, along with their diagnostic and therapeutic applications. Another significant patent is "HCV peptide antigens and method of determining HCV," which describes new HCV peptide antigens suitable for determining HCV antibodies and for use as immunogens in vaccine preparation.

Career Highlights

Throughout his career, Guenther-Gerhard Jung has worked with prominent companies in the pharmaceutical and diagnostics sectors. Notably, he has been associated with Boehringer Mannheim GmbH and Roche Diagnostics GmbH, where he contributed to various innovative projects and research initiatives.

Collaborations

Jung has collaborated with esteemed colleagues in his field, including Josef Endl and Klaus Dornmair. These collaborations have further enhanced his research and development efforts, leading to advancements in immunological studies.

Conclusion

Guenther-Gerhard Jung's contributions to T cell research and his innovative patents have positioned him as a key figure in the field of immunology. His work continues to influence the development of diagnostic and therapeutic strategies for viral infections.